IRIS
NIKOLIC, Dragana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 114
EU - Europa 73
AS - Asia 41
AF - Africa 3
OC - Oceania 1
SA - Sud America 1
Totale 233
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 113
IT - Italia 43
SG - Singapore 23
RU - Federazione Russa 10
CN - Cina 9
RS - Serbia 6
NL - Olanda 5
EG - Egitto 3
FR - Francia 3
AT - Austria 2
DE - Germania 2
GB - Regno Unito 2
HK - Hong Kong 2
IR - Iran 2
AM - Armenia 1
AU - Australia 1
BO - Bolivia 1
CA - Canada 1
JP - Giappone 1
KG - Kirghizistan 1
SA - Arabia Saudita 1
TJ - Tagikistan 1
Totale 233
Salva come PNG Salva come JPEG
Città #
Singapore 22
Belgrade 6
Council Bluffs 6
Ashburn 5
Milan 5
Cairo 3
Pagani 3
Palermo 3
Bari 2
Bologna 2
Catania 2
Forest City 2
Hong Kong 2
London 2
Los Angeles 2
Pandino 2
Paris 2
Rome 2
Romola 2
Shanghai 2
Villaromagnano 2
Zhengzhou 2
Bishkek 1
Boydton 1
Dushanbe 1
La Paz 1
Munich 1
Nuremberg 1
Pisa 1
Quartu Sant'Elena 1
Riyadh 1
San Severo 1
Sandston 1
Santa Clara 1
Springfield 1
Toronto 1
Yerevan 1
Totale 96
Salva come PNG Salva come JPEG
Nome #
Crithmum maritimum Extract Restores Lipid Homeostasis and Metabolic Profile of Liver Cancer Cells to a Normal Phenotype 19
The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes 16
Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study 13
Anti-inflammatory properties of an aldehydes-enriched fraction of grapefruit essential oil 11
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect 11
An overview of statin-induced myopathy and perspectives for the future 10
Cellular Adaptation Takes Advantage of Atavistic Regression Programs during Carcinogenesis 10
Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study 10
Daily Use of Extra Virgin Olive Oil with High Oleocanthal Concentration Reduced Body Weight, Waist Circumference, Alanine Transaminase, Inflammatory Cytokines and Hepatic Steatosis in Subjects with the Metabolic Syndrome: A 2-Month Intervention Study 10
Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia 9
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study 9
Effects of Aging and Diet on Cardioprotection and Cardiometabolic Risk Markers 8
Liraglutide Increases Serum Levels of MicroRNA-27b, -130a and -210 in Patients with Type 2 Diabetes Mellitus: A Novel Epigenetic Effect 8
Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors 7
A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study 7
Weight loss programmes using low carbohydrate diets to control the cardiovascular risk in adolescents (Review) 6
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome 6
Preliminary results of CitraVes™ effects on low density lipoprotein cholesterol and waist circumference in healthy subjects after 12 weeks: A pilot open-label study 6
An evaluation of RVX-208 for the treatment of atherosclerosis 5
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms 5
Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study 5
Drug evaluation: The combination of fenofibrate and simvastatin for the treatment of dyslipidemia: When and for whom? 5
A multicomponent personalized prevention program in the primary care setting: a randomized clinical trial in older people with noncommunicable chronic diseases (Primacare_P3 study) 5
Adipokines and lipoproteins: Modulation by antihyperglycemic and hypolipidemic agents 5
Can the effects of gender, menopause and ageing on lipid levels be differentiated? 4
Natural approaches in metabolic syndrome management 4
Uric acid metabolism in pre-hypertension and the metabolic syndrome 4
Alcoholic liver cirrhosis, more than a simple hepatic disease - A brief review of the risk factors associated with alcohol abuse 4
Choosing an ideal pharmacotherapeutic strategy for dyslipidemia in children 4
Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis 4
The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: Current knowledge and future perspective 4
PPAR agonists, atherogenic dyslipidemia and cardiovascular risk 3
The Role of Nutraceuticals in Statin Intolerant Patients 3
Microenvironmental stress drives tumor cell maladaptation and malignancy through regulation of mitochondrial and nuclear cytochrome c oxidase subunits 3
Anti-cytokine therapy for prevention of atherosclerosis 3
Peroxisome proliferator-activated receptors and atherosclerosis 3
The effect of bergamot on dyslipidemia 3
Effects of chitosan on plasma lipids and lipoproteins: A 4-month prospective pilot study 3
Exosomal Heat Shock Proteins as New Players in Tumour Cell-to-Cell Communication 3
Serum low density lipoprotein subclasses in asthma 3
A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? 3
Oxidative stress and the role of antioxidative treatment in diabetes mellitus 3
Involvement of the ADAM 12 in thrombin-induced rat's VSMCs proliferation 3
Novel anti-obesity drugs and plasma lipids 3
Statins and new-onset diabetes 3
Small, dense LDL: an update 3
Serum lipoproteins are not associated with the severity of asthma 3
EXOSOMES: PROMISING NON-INVASIVE DIAGNOSTIC AND THERAPEUTIC TOOLS 3
Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches 3
The role of fibrate treatment in dyslipidemia: an overview 3
Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials 3
Statin intolerance-an attempt at a unified definition. Position paper from an International Lipid Expert Panel 2
Emerging approaches for the treatment of hypertriglyceridemia 2
Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality 2
Statin intolerance - An attempt at a unified definition. Position paper from an International Lipid Expert Panel 2
Periodontitis, blood lipids and lipoproteins 2
Statin treatment in the elderly: how much do we know? 2
Psoriasis and acute coronary syndrome risk 2
Lifestyle recommendations for the prevention and management of metabolic syndrome: An international panel recommendation 2
Resistin: An inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome 2
Nutraceuticals as lipid-lowering treatment in pregnancy and their effects on the metabolic syndrome 2
Nutraceuticals as an important part of combination therapy in dyslipidaemia 2
Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease 2
Should low high-density lipoprotein cholesterol (HDL-C) be treated? 2
Nutraceuticals in Lipid-Lowering Treatment: A Narrative Review on the Role of Chitosan 2
Incretin-based therapies, glucometabolic health and endovascular inflammation 2
Incretins, pregnancy, and gestational diabetes 2
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: An 18-month prospective study 2
ETC-1002: A future option for lipid disorders? 2
IMPROVE-IT: What have we learned? 2
The extra-glycemic effects of liraglutide: Focus on cardiometabolic markers 2
Gestational diabetes and the metabolic syndrome: can obesity and small, dense low density lipoproteins be key mediators of this association? 2
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study 2
Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes: A prospective pilot study 2
GLP-1 receptor agonists, carotid atherosclerosis and retinopathy 2
Nutraceuticals as new therapeutic strategies for health and wellbeing 2
Regulation of inducible Nitric Oxide synthase (iNOS) and its potential role in insulin resistance, diabetes and heart failure 2
The dissociation of the Hsp60/pro-Caspase-3 complex by bis(pyridyl)oxadiazole copper complex (CubipyOXA) leads to cell death in NCI-H292 cancer cells 2
Management of Statin Intolerance in 2018: Still More Questions Than Answers 2
Gut Microbiota, Obesity and Bariatric Surgery: Current Knowledge and Future Perspectives 2
Subfractions and subpopulations of HDL: An update 2
Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: An 8-month prospective pilot study 2
LDL and HDL subfractions, dysfunctional HDL: treatment options 2
Intensive LDL-cholesterol lowering therapy and neurocognitive function 2
Totale 360
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.285
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202393 0 0 0 0 0 0 0 0 0 0 90 3
2023/2024114 0 0 1 80 0 3 0 2 7 3 5 13
2024/2025153 15 3 38 18 33 43 3 0 0 0 0 0
Totale 360